SEARCH

SEARCH BY CITATION

References

  • 1
    Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927 34.
  • 2
    Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci 1993; 38: 1569 80.
  • 3
    Everhart JE & Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991; 100: 998 1005.
  • 4
    Camilleri M & Choi MG. Irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 2 15.
  • 5
    Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 2120 37.
  • 6
    Mayer EA & Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 271 93.
  • 7
    Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988; 95: 232 41.
  • 8
    Camilleri M & Choi MG. Review Article: Clinical evidence to support current therapies of irritable bowel syndrome. Aliment Pharmacol Ther 1999; 13(Suppl. 2): 48 53.
  • 9
    Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl. II): II43 7.
  • 10
    Prior A & Read NW. Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5-HT3 receptor antagonist, in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 175 80.
  • 11
    Zighelboim J, Talley NJ, Phillips JF, Harmsen WS, Zinsmeister AR. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci 1995; 40: 819 27.
  • 12
    Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5-HT3 antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 543 52.
  • 13
    Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Forster E, Frexinos J. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1998; 12: 849 55.
  • 14
    Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, et al. GR38032F (ondansetron). A selective 5-HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 1990; 35: 477 80.
  • 15
    Houghton LA, Foster J, Whorwell PJ, McDonald JN. Effect of alosetron, a new 5-HT3 antagonist on gastrointestinal transit in normal healthy volunteers. Gastroenterology 1995; 108: A618A618(Abstract).
  • 16
    Kilpatrick GJ, Hagan RM, Oxford AW, North PC, Tyers MB. GR68755 hydrochloride. Drugs Futr 1992; 17: 660 4.
  • 17
    Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacae G. Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992; 5: 75 91.
  • 18
    Camilleri M, Mayer EA, Drossman DA, Heath A, et al. Improvement in pain and bowel function in female irritable bowel syndrome patients with alosetron a 5-HT3-receptor antagonist . Aliment Pharmacol Ther 1999; 13: 1149 59.
  • 19
    Van Elteren PH. On the combination of independent two sample tests of Wilcoxon. Bull Int Stat Inst 1958; 37: 351 61.
  • 20
    Mantel N & Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719 48.
  • 21
    Cann P. An approach to the design of therapeutic trials in IBS. Scand J Gastroenterol 1987; 230: 67 76.
  • 22
    Talley NJ, Nyren O, Drossman DA, Heaton KW, et al. The irritable bowel syndrome: toward optimal design of controlled treatment trials. Gastroenterol Int 1993; 6: 189 211.
  • 23
    Smith RC, Greenbaum DS, Cancouver JB, et al. Gender differences in irritable bowel syndrome. Gastroenterology 1991; 100: 591 5.
  • 24
    Thompson WG. Gender differences in irritable bowel syndrome. Eur J Gastroenterol Hepatol 1997; 9: 299 302.
  • 25
    Silverman DHS, Munakata JA, Mandelkem MA, Hoh CK, Mayer EA. Comparing regional cerebral activity associated with visceral stimuli in male and female patients. J Nucl Med 1997; 38: 273P273P.